Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab.
Santos-Juanes
Jorge
J
Coto
Pablo
P
Mallo
Susana
S
Galache
Cristina
C
Sánchez del Río
José
J
Torre
J C
JC
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007911:Lentigo / Q000209:etiology* / Q000473:pathology; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D012867:Skin / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000068879:Adalimumab